SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 2 filers reported holding SUTRO BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,494 | +230.1% | 15,128 | +342.3% | 0.00% | +100.0% |
Q2 2023 | $15,903 | +105920.0% | 3,420 | +8.1% | 0.00% | – |
Q1 2023 | $15 | +36.4% | 3,165 | +135.7% | 0.00% | – |
Q4 2022 | $11 | -99.9% | 1,343 | -58.7% | 0.00% | – |
Q3 2022 | $18,000 | -40.0% | 3,250 | -43.0% | 0.00% | -100.0% |
Q2 2022 | $30,000 | +200.0% | 5,704 | +362.6% | 0.00% | – |
Q1 2022 | $10,000 | -87.7% | 1,233 | -77.3% | 0.00% | -100.0% |
Q4 2021 | $81,000 | +42.1% | 5,443 | +80.5% | 0.00% | 0.0% |
Q3 2021 | $57,000 | -10.9% | 3,015 | -12.2% | 0.00% | -50.0% |
Q2 2021 | $64,000 | -21.0% | 3,435 | -3.5% | 0.00% | +100.0% |
Q1 2021 | $81,000 | +80.0% | 3,561 | +70.6% | 0.00% | 0.0% |
Q4 2020 | $45,000 | -75.7% | 2,087 | -88.7% | 0.00% | -50.0% |
Q3 2020 | $185,000 | +249.1% | 18,415 | +167.6% | 0.00% | 0.0% |
Q2 2020 | $53,000 | +5200.0% | 6,882 | +6156.4% | 0.00% | – |
Q3 2019 | $1,000 | -92.9% | 110 | -90.8% | 0.00% | -100.0% |
Q2 2019 | $14,000 | +366.7% | 1,202 | +413.7% | 0.00% | – |
Q1 2019 | $3,000 | -93.9% | 234 | -95.8% | 0.00% | -100.0% |
Q4 2018 | $49,000 | – | 5,518 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |